Avalo Therapeutics Inc (AVTX) Stock Price

21.81 ▲ +5.55 (+34.13%)
Open: 22.80 Vol: 22.46M Day's range: 17.69 - 23.71 May 06, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
AVTX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 21.55▲ 21.58▲ 21.48▲ 15.79▲ 15.51▲
MA10 21.51▲ 21.56▲ 19.87▲ 14.81▲ 15.57▲
MA20 21.56▲ 19.54▲ 17.05▲ 14.44▲ 15.71▲
MA50 21.55▲ 16.17▲ 14.94▲ 15.34▲ 12.98▲
MA100 20.25▲ 14.90▲ 14.70▲ 15.85▲ 10.94▲
MA200 17.28▲ 14.63▲ 14.70▲ 14.41▲ 254.33▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.015▲ -0.009▼ 0.563▲ 0.622▲ 0.074▲
RSI 56.572▲ 69.937▲ 80.622▲ 76.374▲ 64.459▲
STOCH 53.204     55.231     74.924     55.749     37.637    
WILL %R -18.391▲ -23.380▲ -19.533▲ -16.964▲ -16.964▲
CCI 85.945     36.815     68.438     409.123▲ 218.147▲
Latest Filters Detected On AVTX
▲ RSI $AVTX RSI(14) Crossed Above 70 Set Alert
▲ MA $AVTX MA(20) Crossed Above MA(200) Set Alert
▲ MACD $AVTX MACD(12,26,9) Crossed Above Zero Set Alert
▲ GAP $AVTX Open Gap Up %5 Set Alert
▲ GAP $AVTX Open Gap Up %3 Set Alert
▲ GAP $AVTX Open Gap Up %2 Set Alert
▲ BREAK $AVTX Price Breaks 60 Days High Set Alert
▲ BREAK $AVTX Price Breaks 30 Days High Set Alert
▲ BREAK $AVTX Price Breaks 20 Days High Set Alert
▲ BREAK $AVTX Price Breaks 10 Days High Set Alert
Avalo Therapeutics Inc News
Avalo Therapeutics Announces Pricing of $375 Million Public Offering
Tuesday, May 05, 2026 08:44 PM
Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a clinical-stage biotechnology company fully dedicated to developing IL-1β based treatments for immune-mediated inflammatory diseases, today ...
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa
Tuesday, May 05, 2026 01:53 PM
Successfully met primary endpoint of HiSCR75 for both doses studied, demonstrating response rates of 42.2% for 150 mg dose (p=0.018) and 42.9% ...
Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Tuesday, May 05, 2026 01:44 PM
Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a clinical-stage biotechnology company fully dedicated to developing IL-1β based treatments for immune-mediated inflammatory diseases, today ...
AVTX historical stock data
date open high low close volume
06/05/26 22.80 23.71 17.69 21.81 22,457,359
05/05/26 13.87 16.30 13.87 16.26 703,642
04/05/26 13.55 14.16 13.52 13.78 393,871
01/05/26 13.53 14.02 12.97 13.71 720,704
30/04/26 13.02 13.55 12.55 13.40 705,598
29/04/26 12.86 13.525 12.51 13.20 754,534
28/04/26 14.24 15.09 12.63 12.86 830,915
27/04/26 13.92 14.82 13.90 14.42 658,367
24/04/26 14.75 15.11 13.73 13.92 741,926
23/04/26 14.50 15.145 14.10 14.75 655,815
Quote Details
52wk Low:3.39
52wk High:23.71
Vol:22.46M
Avg Vol(3m):19.5M
1Y Chng:+457.80%
1M Chng:+56.34%
Add to Watch List
More Information
Index US Composite
Market Cap. 370.54M